More Borrowing Is Not the Answer at Valeant

Valeant Pharmaceuticals International is considering a new round of borrowing. That is one reason investors should consider cashing in after the stock’s big recent rally.

from WSJ.com: Markets http://ift.tt/2xHaISD
via https://ifttt.com/ IFTTT